Healthcare -
Biotechnology - NASDAQ - US
$ 4.725
-3.77 %
$ 214 M
Market Cap
-7.05
P/E
YMAB - OPERATING EXPENSES
Operating Expenses YMAB - Y-mAbs Therapeutics, Inc.
104 M
LAST VALUE
-17.57%
2 YEAR CAGR
4.54%
5 YEAR CAGR
0.00%
10 YEAR CAGR